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Cytomegaloviruses, representatives of the Betaherpesvirinae, cause opportunistic infections in 
immunocompromised hosts. They infect various cells and tissues in their natural host but are highly 
species specific. For instance, human cytomegalovirus (HCMV) does not replicate in mouse cells, and 
human cells are not permissive for murine cytomegalovirus (MCMV) infection. However, the 
underlying molecular mechanisms are so far poorly understood. In the present study we isolated and 
characterized a spontaneously occurring MCMV mutant that has gained the capacity to replicate 
rapidly and to high titers in human cells. Compared to the parental wild-type (wt) virus, this mutant 
formed larger nuclear replication compartments and replicated viral DNA more efficiently. It also 
disrupted promyelocytic leukemia (PML) protein nuclear domains with greater efficiency but caused 
less apoptosis than did wt MCMV. Sequence analysis of the mutant virus genome revealed mutations 
in the M112/M113-coding region. This region is homologous to the HCMV UL112-113 region and 
encodes the viral early 1 (E1) proteins, which are known to play an important role in viral DNA 
replication. By introducing the M112/M113 mutations into wt MCMV, we demonstrated that they are 
sufficient to facilitate MCMV replication in human cells and are, at least in part, responsible for the 
efficient replication capability of the spontaneously adapted virus. However, additional mutations 
probably contribute as well. These results reveal a previously unrecognized role of the viral E1 
proteins in regulating viral replication in different cells and provide new insights into the mechanisms of 
the species specificity of cytomegaloviruses. 
 
 
Cytomegaloviruses (CMVs) are prototypes of the subfamily of the Herpesviridae. Representatives of 
this subfamily have been identified in various animal species, and these viruses cause similar 
symptoms in their respective hosts (36). HCMV is an opportunistic pathogen that causes generally 
mild infections in people with a fully functional immune system. However, this virus is also responsible 
for serious medical problems, particularly in newborns and immunocompromised patients (39). 
 
Since their first isolation in cell culture, CMVs have been recognized as highly species specific (57). 
They replicate only in cells of their own or a closely related species. For instance, simian CMV can 
replicate in human fibroblasts (32), and HCMV can replicate in chimpanzee skin fibroblasts (41). 
Similarly, murine cytomegalovirus (MCMV) productively infects rat cells (7, 46), but a rat 
cytomegalovirus did not replicate in murine fibroblasts (7). However, cells of other more distantly 
related species are usually nonpermissive to infection. Several studies have shown that CMVs can 
enter cells of other species and express a subset of viral genes (19, 20, 29, 32). This finding has led to 
the conclusion that the restriction to CMV replication in nonpermissive cells is associated with a 
postpenetration block to viral gene expression and DNA replication but not due to a failure to enter the 
cell (36). 
 
Recently, we picked up on this topic and tried to gain new insights into the molecular mechanisms 
underlying the species specificity of CMVs. We showed that CMVs of mice and rats induce apoptosis 
when they infect human fibroblasts or retinal epithelial cells (26). The induction of apoptosis prevented 
a sustained replication of these viruses in human cells and reduced progeny production to insignificant 
levels. When apoptosis was inhibited by the overexpression of Bcl-2 or a functionally similar protein, 
MCMV was able to replicate to substantial titers in human cells. These results indicated that the 
induction of apoptosis is an important limitation to cytomegalovirus cross-species infections (26). 
However, the fact that MCMV replication in human cells in the presence of apoptosis inhibition was 
somewhat delayed and less efficient than that in murine cells indicated that other limiting factors likely 
  
exist. Another study suggested that MCMV can replicate to low levels in human cells with the help of 
HCMV immediate- early 1 (IE1) and HCMV tegument proteins (50). 
 
In the present study, we describe the isolation and characterizationof a mutant MCMV that has 
spontaneously acquired the ability to replicate rapidly and to high titers in human retinal pigment 
epithelial (RPE-1) cells. We show that this virus induces less apoptosis and replicates its DNA faster 
than the parental wild-type (wt) MCMV. Moreover, the mutant virus disrupts intranuclear sites of 
intrinsic antiviral defense more efficiently than the wt virus. Sequence analysis of the human cell-
adapted MCMV strain revealed several alterations, including mutations in the M112/M113- coding 
region. By targeted mutagenesis we showed that mutations in M112/M113 are sufficient to facilitate 
MCMV replication in human cells. However, additional mutations most likely contribute to the 
remarkably efficient replication of the adapted strain. 
 
 
Materials and methods 
 
Cells and viruses.  
hTERT RPE-1 (ATCC CRL-4000) cells are telomeraseimmortalized retinal pigment epithelial cells (6). 
MRC-5 cells (ATCC CCL-171) are primary human embryonic lung fibroblasts. 10.1 cells are 
spontaneously immortalized murine embryonic fibroblasts (22). Primary human foreskin fibroblasts 
(HFFs) were a gift from Jens von Einem (University of Ulm, Ulm, Germany), and primary human 
umbilical vein endothelial cells (HUVECs) were provided by Regine Heller (University of Jena, Jena 
Germany). HUVECs were cultured in complete endothelial cell growth medium (Promocell). All other 
cells were cultured in complete Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% 
fetal calf serum at 37°C and 5% CO2 in a humidifiedatmosphere. wt and mutant MCMVs were 
propagated in 10.1 fibroblasts as described previously (26). MCMV/h was propagated in human RPE-
1 cells. Bacterial artificial chromosome (BAC)-derived HCMV strains AD169 and TB40/E (23, 45) were 
propagated on MRC-5 fibroblasts. MCMV titers were determined on mouse 10.1 cells and HCMV titers 




Plasmids and transfection.  
The M112/M113-coding sequence plus 50-nucleotide (nt) extensions on either side (for homologous 
recombination) were PCR amplified from wt MCMV and MCMV/h by using primers M112_Not_fwd 
(GTT-CCT-GCG-GCC-GCG-GTA-GAT-TAC-GTG-CCC-ACT-TTTC) and M113_Pst_Mfe_rev (CAA-
CTG-CAG-TCA-GTT-AGA-GTT-TAC-AGA-GCATCA-TTT-CTT-TAT-CCA-TCT-TTCAATTGA-GAT-
CAA-TTA-AGA-TCATCG-AACACA). The amplification products were cleaved with NotI and PstI 
(underlined), cloned into pBluescript KS(+), and verified by sequencing. An Flp recombination target 
(FRT)-flanked kanamycin resistance gene (excised with EcoRI from pSLFRTkn [5]) was cloned into 
the MfeI site (underlined) located behind the M112/M113-coding region, yielding plasmids pBS-M112-
kn and pBSM112mut-kn. For protein expression by transient transfection, the M112/M113- coding 
sequence (without the kan cassette) was excised with NotI and PstI from the pBluescript backbone 
and inserted into pFlagCMV5a (Sigma). Plasmid pp89UC, encoding MCMV IE1, and pcDNA-IE1, 
encoding HCMV IE1, were kindly provided by Martin Messerle (Hannover Medical School, Hannover, 
Germany) and Michael Nevels (University of Regensburg, Regensburg, Germany), respectively. The 
green fluorescent protein (GFP) expression plasmid pEGFP-C1 was obtained from Clontech. Plasmid 
transfections were done by using Polyfect transfection reagent (Qiagen).  
 
 
Generation of gene knockdown cells.  
Plasmids carrying the short hairpin RNA (shRNA) expressing retroviral vectors pHM2237/empty, 
pHM2238/shC, pHM2240/shDaxx1, and pHM2243/shPML2 (52) were kindly provided by Thomas 
Stamminger and Nina Tavalai (University of Erlangen, Erlangen, Germany). Retroviruses were 
produced by transfecting the vector plasmids into the Phoenix Ampho packaging cell line by calcium 
phosphate transfection, as described previously (48), and were used for the transduction of RPE-1 
cells. Nonclonal cell populations stably expressing shRNA were obtained by selection with 5 µg/ml 





Antibodies and immunodetection.  
Monoclonal antibodies against the MCMV IE1 (CROMA101) and early 1 (E1) (CROMA103) proteins 
were provided by Stipan Jonjic (University of Rijeka, Rijeka, Croatia), monoclonal antibodies against 
M44 (3B9.22A) and MCMV glycoprotein B (gB) (2E8.21A) were provided by Lambert Loh (University 
of Saskatchewan, Saskatoon, Saskatchewan, Canada), and monoclonal antibodies against HCMV IE1 
(1B12) were provided by Thomas Shenk (Princeton University, Princeton, NJ). A polyclonal rabbit 
antiserum against MCMV IE3 was provided by Eva Borst (Hannover Medical School, Hannover, 
Germany). Antibodies recognizing the promyelocytic leukemia (PML) protein (H-238; Santa Cruz 
Biotechnology), hDaxx (E94; Epitomics), and β-actin (AC-74; Sigma) were purchased from the 
indicated suppliers.  
 
For immunofluorescence analyses cells were seeded onto coverslips on the day before 
infection/transfection. After 24 h, cells were washed twice with phosphatebuffered saline (PBS), fixed 
for 30 min at 4°C with 4% paraformaldehyde, neutralized with 50 mM ammonium chloride, 
permeabilized with 0.3% Triton X-100, and blocked with 0.2% cold-water fish gelatin (Sigma). Proteins 
of interest were detected by indirect immunofluorescence using secondary antibodies coupled to Alexa 
Fluor 568 or Alexa Fluor 488 (Invitrogen). Nuclei were counterstained with 4’,6’-diamidino-2-
phenylindole (DAPI). Confocal laser scanning microscopy was performed by using a Zeiss LSM510 
Meta microscope. To analyze PML disruption or the formation of replication compartments, at least 
three different experiments were done, and a minimum of 150 infected cells from each experiment 
were evaluated.  
 
For Western blot analyses, cells were infected at a multiplicity of infection (MOI) of 5 TCID50/cell, 
harvested at the indicated time points, and lysed with lysis buffer containing 20 mM Tris-HCl (pH 7.5), 
300 mM NaCl, 1% Na-deoxycholate 1% Triton X-100, and 0.1% SDS. Proteins samples were 
separated by SDS-PAGE and transferred onto positively charged nitrocellulose membranes. Proteins 
of interest were detected by using protein-specific primary antibodies, horseradish peroxidase-coupled 




BAC mutagenesis.  
All recombinant viruses were constructed on the basis of MCMV-GFP (9) by using BAC technology 
(11). To construct the ΔM112/M113 mutant, a zeocin resistance gene was PCR amplified by using 
primers M112_zeo_fwd (5’-ACG-TGC-CCA-CTT-TTC-TCG-TCG-CGA-CCG-GTGAAA-AGA-CCT-
TCG-TTC-GGA-CCT-gtt-gac-aat-taa-tca-tcg-gcat-3) and M113_zeo_rev (5’-AGT-CAG-TTA-GAG-TTT-
ACA-GAG-CAT-CAT-TTCTTT-ATC-CATCTTT-CAT-GAG-At-cag-tcc tgc-tcc-tcg-gcca-3) to introduce 
50-nt homology arms (shown in uppercase type) upstream and downstream of the M112/M113-coding 
region. This linear PCR fragment was used for homologous recombination in Escherichia coli strain 
DY380 containing the MCMVGFP BAC (10). Mutant BACs were analyzed by restriction digestion and 
agarose gel electrophoresis. In a second step, linear fragments containing the wt or mutant 
M112/M113-coding sequence and the kanamycin cassette were excised with NotI and PstI from 
plasmids pBS-M112-kn and pBS-M112mut-kn, respectively, and used for homologous recombination. 
Clones were selected with kanamycin, and recombinant BACs were analyzed by restriction digestion. 
The kanamycin cassette was removed by using Flp recombinase as previously described (10). An 
independent M112/M113 mutant virus was constructed by using the galK system (56). Briefly, an Δ 
M112/M113 mutant was constructed as described above by using galK instead of zeo for positive 
selection. In a second step, the mutant M112/M113 sequence was reinserted by using galK for 
negative selection. Mutant and control viruses were reconstituted by transfecting purified BAC DNA 
into mouse fibroblasts using Polyfect transfection reagent (Qiagen).  
 
 
Genome sequencing.  
MCMV/h was derived from a single plaque of infected RPE-1 cells and was passaged continuously on 
RPE-1 cells. For the preparation of MCMV/h virion DNA, viral particles in the supernatant of infected 
RPE-1 cultures were pelleted by centrifugation for 3 h at 25,000 x g. Pellets were resuspended in a 
solution containing 10 mM Tris-HCl (pH 7.8), 5 mM EDTA, and 0.5% SDS; digested overnight with 50 
μg/ml proteinase K at 56°C; and finally subjected to phenol-chloroform extraction and DNA 
precipitation. Purified DNA was analyzed by restriction digestion. High-quality virion DNA was sent to 
Macrogen for shotgun sequencing. The resulting contigs were aligned, and the remaining gaps were 
filled by primer walking. In this way, almost the entire MCMV/h genome was sequenced save for a few 
kilobases at the genome termini.  
  
Growth kinetics.  
For growth kinetics, cells were seeded into six-well dishes and infected with the viruses of interest. At 
4 h postinfection (hpi), the medium was removed, cells were washed twice with PBS, and fresh 
medium was added. At the indicated time points, titers in the supernatant were determined by using 
the TCID50 method. All growth kinetic experiments were done in triplicate.  
 
 
Southern blot analysis and real-time PCR.  
Cells were infected at an MOI of 5 TCID50/cell for 4 h. At the indicated time points, adherent and 
detached cells were collected, and complete genomic DNA was extracted by proteinase K digestion 
and phenol-chloroform extraction. For slot blot analysis, 1 g of DNA of each sample was denatured for 
10 min at 95°C in 6 SSC (0.9MNaCl, 90 mM Na-citrate [pH 7.0]), cooled rapidly on ice, transferred 
onto a nylon membrane by vacuum suction using a slot blot apparatus (Roth), and fixed by using a UV 
cross-linker (Stratagene). For Southern blot analysis, equal amounts of DNA were digested with 
EcoRI, separated by gel electrophoresis, and blotted onto a nylon membrane. Hybridization with a 
digoxigenin (DIG)-labeled MCMV M45 probe and detection by ECL were done by using a DIG-High 
Prime DNA labeling and detection kit (Roche). 
 
For real-time PCR analysis cells were infected at an MOI of 0.5 TCID50/cell, and DNA was extracted at 
the indicated time points by using the DNeasy blood and tissue kit (Qiagen). A SYBR green PCR 
master mix (ABI Applied Biosystems) was used for the quantitative detection of the cellular myc gene 
and the viral IE1 gene. The appropriate primers were described previously (8, 55). For the 
determination of viral and cellular genome copies, defined dilutions of plasmids containing the cloned 




Cell viability and cell death assays.  
Cell viability was measured by using a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2Htetrazolium (MTS) assay (CellTiter 96 AQueous; Promega). Mean values and standard 
deviations of data from at least six parallel experiments are shown. Significance levels were calculated 
by using a Student’s t test. To analyze DNA fragmentation as a sign of apoptosis, cells were grown on 
coverslips and infected at an MOI of 5 TCID50/cell. Nuclear DNA fragmentation was detected by using 
a terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labelling (TUNEL) assay (TMR 






Isolation of a mutant MCMV spontaneously adapted to human cells.  
In a previous study we showed that MCMV does not replicate to significant levels in human cells and 
that infected human cells undergo apoptosis. The inability of MCMV to replicate and spread in human 
cells could be overcome by overexpressing a Bcl-2-like antiapoptotic protein (26). During one of our 
experiments, we fortuitously observed the spontaneous outgrowth of a rapidly spreading virus in a cell 
culture dish of human retinal pigment epithelial (RPE-1) cells that had been infected 2 weeks earlier 
with MCMV-GFP, a GFP-expressing MCMV variant. We named this spontaneously arisen mutant 
MCMV/h to indicate its adaptation to human cells. MCMV/h expressed GFP, caused a typical 
cytopathic effect (CPE), formed plaques, and could be serially passaged on RPE-1 cells. Moreover, it 
grew much faster and to higher titers than MCMV-bclXL (26), a mutant MCMV that overexpresses Bcl-
xL, in RPE-1 cells, human embryonic lung fibroblasts (MRC-5), human foreskin fibroblasts (HFFs), and 
human umbilical vein endothelial cells (HUVECs) (Fig. 1A to F). In MRC-5 fibroblasts, MCMV/h did not 
replicate as efficiently as in RPE-1 cells upon low-MOI infection (Fig. 1D). By microscopic inspection 
we observed that MCMV/h was capable of spreading from the initially infected fibroblasts to 
neighboring cells, forming foci and even small plaques of infected (GFPpositive) cells. After a few 
days, these foci stopped expanding and gradually regressed (data not shown). The same replication 
phenotype was observed for HFFs, and the virus replicated to almost identical titers in these cells 
(data not shown). 
 
The reason for this limited replication in human fibroblasts after low-MOI infection is so far unknown. In 
murine fibroblasts, however, the virus replicated to titers similar to those of 
  
parental MCMV-GFP even after low-MOI infection (Fig. 1G). MCMV/h replicated only transiently in 
HUVECs after high- MOI infection (Fig. 1F) and to titers at or below the detection limit after low-MOI 
infection (data not shown). Virion DNA was extracted from an MCMV/h stock grown on RPE-1 cells 
and subjected to EcoRI and NheI restriction. The restriction patterns of MCMV/h DNA were very 
similar to the patterns of MCMV-GFP. However, a few differences were evident (Fig. 1H), suggesting 
that genetic alterations had occurred. The transfection of purified MCMV/h DNA into RPE-1 cells 
resulted in a reconstitution of infectious MCMV/h. This largely ruled out the possibility that the 
replication of MCMV/h in human cells was caused by the presence of an undetected helper RNA virus, 
as RNA viruses would not withstand the DNA purification procedure. To exclude a possible 
contamination with HCMV, BAC DNA of HCMV laboratory strain AD169 was included. The digestion 




Phenotypic characterization of MCMV/h.  
We have previously described that MCMV induces apoptosis in infected human cells (26). Compared 
to wt MCMV, MCMV/h induced less apoptosis, as seen morphologically by microscopic inspection as 
well as by analyzing nuclear DNA fragmentation with a TUNEL assay (Fig. 2A and B). MCMV/h 
decreased the viability of infected RPE-1 cells, as measured by an MTS assay, but the loss of viability 
was less pronounced than that after infection with the parental virus, MCMV-GFP (Fig. 2C). The 
viability of murine fibroblasts remained largely unaltered between 24 and 72 hpi, no matter whether the 
cells had been infected with wt or mutant MCMVs (Fig. 2D). Next, we analyzed viral gene expression 
in human and murine cells. The expressions of the immediate-early 1 (IE1), early 1 (E1), M44, and 
glycoprotein B (gB) proteins as representatives 
of the immediate-early, early, early-late, and late kinetic classes, respectively, were measured by 
Western blotting at different times postinfection. In murine fibroblasts, viral protein expression levels in 
cells infected with MCMV/h were very similar to those in cells infected with the parental virus with the 
exception of gB, whose expression level rose slightly earlier in MCMV/h-infected cells (Fig. 3A). In 
RPE-1 cells, the MCMV/h protein expression pattern was quite similar to the one observed for 10.1 
fibroblasts. However, M44 expression was delayed in RPE-1 cells, and gB expression was lower at 24 
hpi. In contrast, viral protein expression vanished in wt MCMV-infected cells between 48 and 72 hpi, 
because infected cells had died (Fig. 3A), consistent with previous observations (26). Viral DNA 
replication was observed only transiently in wt MCMV-infected RPE-1 cells but occurred efficiently in 
MCMV/h-infected cells, as determined by slot blot analysis and real-time PCR (Fig. 3B and C). 
 
 
Sequence analysis of MCMV/h reveals genetic alterations.  
We wondered whether a genetic alteration or an epigenetic modification of the MCMV genome was 
responsible for the ability of MCMV/h to replicate efficiently in human cells. As MCMV/h retained its 
ability to replicate in RPE-1 cells even after repeated passage in murine fibroblasts (data not shown), 
we considered it unlikely that an epigenetic modification, which might have occurred in human cells, 
was responsible. Moreover, the changes in the restriction pattern of MCMV/h compared to the 
expression pattern of the parental virus (Fig. 1H) suggested that the phenotype could have been 
caused by one or more mutations in the viral genome. As the sequencing of a few candidate genes 
(such as genes with known antiapoptotic functions) did not reveal any differences from wt MCMV, we 
decided to have the whole MCMV/h genome sequenced. The MCMV/h sequence was then compared 
to the previously reported MCMV Smith sequence (42). The results of this comparison are listed in 
Table 1. The most striking alteration was a 10.3-kb deletion (nt 9561 to 19848, open reading frames 
[ORFs] m10 to m18) combined with a 12.5-kb inverted duplication of ORFs m58 to m73 (nt 91689 to 
104152). In addition, several point mutations and small deletions were detected. Some of these were 
also found in the parental MCMV BAC, suggesting that they are probably not responsible for the 
phenotype of MCMV/h. As MCMV/h originated from a single plaque of infected RPE-1 cells and was 
passaged repeatedly on the same cell line, we assumed that MCMV/h represents a single mutant 
clone. However, we did not subject this virus to numerous rounds of plaque purification, which would 
be necessary to formally exclude the possibility that MCMV/h consists of more than one mutant clone. 
 
To analyze which of the detected mutations contributed to the extended-host-range phenotype of 
MCMV/h, we decided to engineer selected mutations into the wt MCMV-GFP genome. The deletion of 
the region of m10 to m18 did not facilitate MCMV replication in RPE-1 cells (data not shown), 
indicating that this region does not contain a gene that actively restricts MCMV’s host range. The 
reconstruction of the duplication spanning ORFs m58 to m73 is technically very difficult and was 
therefore deferred. 
  
Mutations in M112/M113 facilitate MCMV replication in RPE-1 cells.  
Next, we focused on the mutations in M112/M113. This region encodes the E1 proteins, which exist in 
at least four differentially spliced isoforms (13, 16) (Fig. 4A). It is highly homologous in its structure to 
the UL112-113 region of human cytomegalovirus (16, 47, 60). Although the mechanisms of action of 
the E1 proteins have not been fully elucidated, a number of studies have shown that they play an 
important role in the formation of nuclear replication compartments (4, 38, 40), in viral DNA replication 
(37, 61), and in the regulation of gene expression (24, 28, 49). Hence, we thought that the mutations 
in M112/M113 might play a role in the ability of MCMV/h to replicate in human cells. 
 
MCMV/h contains a 9-nucleotide deletion in M112/M113 that should result in a 3-amino-acid deletion 
affecting all four E1 isoforms (Table 1 and Fig. 4A). In addition, two point mutations were present, 
which were predicted to cause amino acid exchanges only in the large 87-kDa isoform. A third point 
mutation at position 163813 is likely silent. To test whether these mutations influence MCMV 
replication in RPE-1 cells, we first deleted the entire E1-coding region from the MCMVGFP BAC as 
shown in Fig. 4B. We then reinserted either the wt or the mutant M112/M113 sequence. The resulting 
BACs were named RevM112 and M112mut, respectively. The recombinant MCMV BACs were verified 
by restriction digestion (Fig. 4C) and transfected into fibroblasts to obtain recombinant viruses. The 
M112mut and RevM112 viruses were easily reconstituted, but numerous attempts to reconstitute the 
M112/M113 deletion mutant were unsuccessful. This indicated either that the E1 proteins are essential 
for MCMV replication or that viral replication is so severely compromised in their absence that a 
deletion mutant can be regenerated only in complementing cells. RevM112 and M112mut replication 
in murine fibroblasts was indistinguishable from that of the parental virus (data not shown). RevM112 
also behaved like the parental wt virus in that it did not replicate in RPE-1 cells. In contrast, M112mut 
replicated to high titers in RPE-1 cells (Fig. 5A). 
 
However, it did not replicate as rapidly as MCMV/h, suggesting that additional mutations present in 
MCMV/h must contribute to its highly efficient replication in human cells. To exclude the possibility that 
the FRT site, which remained behind the M112/M113-coding region (Fig. 4B), had a negative influence 
on the replication of M112mut, we constructed an independent M112/M113 mutant MCMV using the 
galK system (56). The resulting virus replicated with the same kinetics in RPE-1 cells as M112mut 
(data not shown), indicating that the FRT site did not have a detrimental effect. We also tested to 
which extent the constructed viruses induced cell death in  RPE-1 cells. Again, RevM112 behaved like 
the parental wt virus, and M112mut displayed an intermediate phenotype; it induced apoptosis less 
efficiently than wt MCMV but more efficiently than MCMV/h (Fig. 5B). Next, we asked whether the 
mutations in M112/M113 had an impact on the abundance of individual E1 protein isoforms in infected 
RPE-1 cells. As shown in Fig. 6A, the abundances of the 36- and 38-kDa E1 proteins were similar for 
all viruses up to 48 hpi. The 33-kDa isoform was not detected by the CROMA103 antibody, 
presumably because CROMA103 recognizes an epitope encoded by exon 2. The expression of the 
87-kDa E1 protein was maintained up to 96 hpi in cells infected 
with MCMV/h or the M112mut virus but was reduced at 48 hpi and almost absent at later times in cells 
infected with wt MCMV or the revertant, RevM112. As the large E1 isoform was previously reported to 
control the repressive effect of IE3 on the major immediate-early (MIE) promoter (49), we tested 
whether the loss of the 87-kDa E1 protein correlated with a educed level of expression of the MIE 
proteins IE1 and IE3. No obvious differences in the abundances of IE1 and IE3 were detected up to 24 
hpi (Fig. 6A), but at later times (particularly at 72 and 96 hpi), the IE1 and IE3 levels were reduced. 
However, it is difficult to determine to which extent this effect was caused by the 87-kDa E1 protein, 
because the onset of cell death, which starts at around 48 hpi and is more pronounced in wt- and 
RevM112-infected cells, impairs viral protein and DNA levels in general. 
 
The E1 proteins form intranuclear structures that also contain IE3 and viral DNA polymerase and 
accumulate viral DNA (4, 49). Therefore, they are considered to represent replication compartments. 
They start out as small punctate foci that coalesce to a large lobulated compartment at late times after 
infection (13, 40). To test whether wt and mutant MCMVs differ in their abilities to form replication 
compartments, we analyzed the distributions of the E1, IE3, and M44 proteins in infected RPE-1 cells 
by immunofluorescence. In all cases, IE3 colocalized in nuclear replication compartments with the 
DNA polymerase processivity factor M44 and the E1 proteins, but there were clear differences in the 
sizes of the replication ompartments (Fig. 6B and C). A statistical evaluation revealed that the majority 
of cells infected with MCMV/h contained large lobulated replication compartments, whereas only 
small punctate structures were found in the vast majority (> 80%) of cells infected with wt MCMV or 
the revertant, RevM112 (Fig. 6D). As in previous experiments, the constructed M112mut mutant 
showed an intermediate phenotype, with large lobulated replication compartments in approximately 
  
40% of infected RPE-1 cells and small punctate replication foci in approximately 60% of infected RPE-
1 cells. 
 
HCMV and MCMV DNA replication compartments initiate from the periphery of promyelocytic 
leukemia protein-associated nuclear bodies (PML bodies, also known as ND10) (4, 49). The PML 
bodies contain proteins such as PML, Daxx, and Sp100, which can function as transcriptional 
repressors (18, 34, 53). At early times after CMV infection, PML bodies are dispersed, and the PML 
protein is found diffusely distributed throughout the nucleus (3, 21, 31, 44, 58). ND10 disruption has 
been correlated with efficient viral gene transcription and DNA replication (2). Hence, we wondered 
whether MCMV was capable of disrupting PML domains in human RPE-1 cells. As shown in Fig. 7A 
and B, ND10 disruption was observed for only a minority of wt MCMV-infected cells but for the majority 
of MCMV/h-infected cells. The M112mut mutant also had an increased ability to disrupt PML bodies 
but was less efficient than MCMV/h (Fig. 7B). This raised the question of whether the E1 proteins 
encoded by the M112/M113 locus were responsible for the ND10 disruption or whether these proteins 
promote ND10 disruption more indirectly. To resolve this question, we tested if E1 proteins expressed 
from a plasmid vector were able to disrupt PML bodies. Neither the E1 proteins expressed from a wt 
M112/M113 gene sequence nor those expressed from the MCMV/h-derived mutant M112/M113 gene 
were able to disperse PML nuclear domains. In contrast, the transfection of an MCMV IE1 expression 
plasmid resulted in the efficient disruption of PML domains, similar to the effect of HCMV IE1 (Fig. 7C). 
These results suggested that the viral E1 proteins did not disrupt ND10 by themselves but rather 
promoted ND10 disruption by an indirect mechanism. 
 
Recent studies have corroborated the repressive effect of PML and hDaxx on HCMV replication by 
showing that the elimination of these proteins by small interfering RNA (siRNA)-mediated gene 
knockdown enhances viral replication (51, 52, 59). Based on these observations we reasoned that a 
knockdown of PML or hDaxx might also facilitate MCMV replication in human RPE-1 cells. Therefore, 
we used previously described shRNA-expressing retroviruses (52) to generate stable PML and hDaxx 
knockdown cells (Fig. 7D) and analyzed MCMV replication in these cells. As shown in Fig. 7E, PML 
knockdown did not facilitate the replication of wt MCMV in RPE-1 cells but enhanced the replication of 
the M112mut mutant. In contrast, the knockdown of hDaxx decreased the replication of M112mut in 
RPE-1 cells (Fig. 7E). The reason for the decreased replication in Daxx knockdown cells is unclear. 
However, it seems likely that a previously reported increased sensitivity of Daxx knockdown cells to 
proapoptotic stimuli is responsible (14, 35). 
 
Taken together, this study shows that MCMV can spontaneously gain the ability to replicate in human 
cells by acquiring a few small mutations in the M112/M113-coding region. These 
mutations decrease the proapoptotic effect of MCMV infection on human cells and increase the 
formation of replication compartments and the efficiency of viral DNA replication. The mutations also 
enhance the ability of MCMV to disrupt PML nuclear domains. However, PML-mediated repression of 
viral transcription and/or replication does not seem to be the primary barrier to cross-species infection 
but rather limits its efficiency. The introduction of the M112/M113 mutations into wt MCMV did not fully 
reproduce the remarkably rapid replication of MCMV/h in human RPE-1 cells, suggesting that 





In this study we describe and characterize an MCMV mutant that has spontaneously obtained the 
capacity to replicate in human cells. At first, the identification of this mutant virus was surprising to us. 
However, a literature search revealed that a spontaneous adaptation of MCMV to human cells has 
been seen before. In 1969, Raynaud and colleagues described the adaptation of a field mouse 
(Apodemus sylvaticus) cytomegalovirus to monkey kidney cells and human diploid cells by first 
passaging it through embryonic hamster cells and a baby hamster kidney (BHK21) cell line (43). In 
monkey kidney cells, their virus replicated to a titer of 107 TCID50/ml, a titer similar to the titer that our 
MCMV/h isolate reached in human RPE-1 cells. A later study by Kim et al. compared the Raynaud 
strain (prior to adaptation) to the MCMV Smith strain and found that the two strains were 
indistinguishable in terms of replication kinetics, CPE morphology, virus particle density, and antibody 
cross-reactivity, suggesting that the two viruses were identical (30). Kim and colleagues concluded 
that the virus must have undergone a remarkable change during tissue culture passage or that the 
virus that replicated in human cells was a contaminant and not the original mouse virus. As the studies 
  
by Raynaud et al. and Kim et al. were done before the advent of molecular biology, it is impossible to 
tell whether the two MCMV strains were genetically identical or only similar in their phenotypes. Be 
that as it may, the present study clearly shows that even the MCMV Smith strain can spontaneously 
adapt to human cells and reveals a genetic basis for this extended- host-range phenotype. 
 
In a previous study we showed that MCMV induces apoptosis in human cells and that an inhibition of 
apoptosis allows the virus to replicate in human cells (26). Surprisingly, the human cell-adapted 
MCMV/h still induced apoptosis in a large proportion of infected RPE-1 cells, although it was less than 
that induced by the parental wt virus (Fig. 2C). A sequence analysis of MCMV/h also did not reveal 
any mutations in known antiapoptotic genes of MCMV or in MCMV homologs of HCMV cell death 
suppressors. Instead, we demonstrated that mutations in the M112/M113-coding sequence facilitate 
MCMV replication in human cells and are at least in part responsible for the remarkably efficient 
growth of MCMV/h in RPE-1 cells. The mutations in MCMV/h enabled the virus to express its proteins 
and replicate its DNA faster or more efficiently than the parental wt virus (Fig. 3 and 6A). On the other 
hand, the mutant virus also induced less apoptosis than wt MCMV (Fig. 5B), and this most probably 
contributed to the enhanced protein expression and DNA replication. However, MCMV/h still has a 
more pronounced apoptosis-inducing effect on human cells than on murine cells. MCMV/h titers drop 
quite rapidly after high-MOI infection of human cells, particularly if sensitive cells such as HUVECs are 
used (Fig. 1F). Hence, MCMV/h is not yet perfectly adapted to human cells, and apoptosis of infected 
cells must still be considered an important limitation for MCMV cross-species infections. 
 
The MCMV M112/M113 and the HCMV UL112-113 regions are highly similar in their locations within 
the viral genome and share an almost identical splicing pattern (16). Differentially spliced mRNAs 
encode at least four protein products of 33, 36, 38, and 87 kDa in the case of MCMV (16) and 34, 43, 
50, and 84 kDa in the case of HCMV (60). Secondary modifications such as phosphorylation are 
responsible for differences between the predicted and the apparent molecular weights of some of the 
protein variants (13, 60). Although the E1 proteins were identified many years ago, their mechanisms 
of action remain poorly understood. E1 proteins become detectable shortly after the major immediate-
early proteins (4, 
13), suggesting that very little IE protein is necessary to activate the 112/113 promoter. Together with 
the MIE proteins, the E1 proteins can enhance the expression of other viral genes, particularly those 
involved in DNA replication (24, 28). In addition, the E1 proteins may also have a more direct role in 
viral DNA replication, as they can bind single- and doublestranded DNA and accumulate at nuclear 
replication sites (25). Moreover, UL112-113 proteins are necessary for the transient complementation 
of HCMV oriLyt-dependent DNA replication (37), and antisense RNA to UL112-113 transcripts inhibits 
viral DNA replication (61). 
 
It seems likely that the different E1 protein isoforms have nonidentical functions, but how the different 
isoforms function and how they interact with each other and with other proteins have only begun to be 
understood. Of the three relevant mutations in MCMV/h, one mutation (the 3-amino-acid deletion) 
affects all E1 protein isoforms, whereas the two point mutations lead to amino acid exchanges only in 
the large 87-kDa isoform (Fig. 4A). However, we cannot exclude that the point mutations have an 
impact on splicing efficiency and shift the balance between the various E1 isoforms. The higher 
abundance of the 87-kDa E1 protein at late times postinfection (Fig. 6A) might indeed reflect altered 
splicing but might also be based on differences in protein stability between the wt and the mutant 87-
kDa proteins. Interestingly, it was recently shown that the 87-kDa protein interacts with IE3 and 
modulates the repressive effect of IE3 on the MIE promoter (49). However, marked differences in IE1 
or IE3 levels between wt and mutant viruses were detected only from 48 hpi onward (Fig. 6A), the 
same time when massive cell death starts, particularly in cells infected with wt MCMV. Hence, it is 
difficult to determine the contributions of the 87-kDa E1 protein and cell death to the reduced IE1 and 
IE3 levels, respectively. In fact, previous work has shown that extended cell survival due to the 
expression of an antiapoptotic protein correlated with higher levels of viral protein expression at 72 
and 96 hpi (26). PML nuclear domains (ND10) consist predominantly of proteins functioning as 
transcriptional repressors (18, 34, 53). Viral genomes are frequently detected in close association with 
PML domains, suggesting that the PML domains exert a cellintrinsic antiviral defense. This notion is 
supported by the fact that some DNA viruses are capable of dispersing PML nuclear bodies (18, 34, 
53). Moreover, the inactivation of PML, Daxx, or Sp100 by gene knockdown significantly enhances 
viral replication in permissive cells (52, 53, 59). However, can the disruption of PML structures also 
facilitate virus replication in cells that are usually nonpermissive for a particular virus? We previously 
constructed MCMV-hIE1 (an MCMV mutant expressing HCMV IE1), and this virus did not replicate to 
significant titers in human RPE-1 cells or MRC-5 fibroblasts (26), even though it disrupted ND10 in 
more than 60% of infected RPE-1 cells (data not shown). Moreover, a knockdown of PML or Daxx in 
  
the same cells did not facilitate the replication of wt MCMV (Fig. 7E), indicating that ND10 disruption 
alone is not sufficient for MCMV to replicate and spread efficiently. However, PML knockdown did 
enhance the replication of the M112mut virus. Interestingly, using the same MCMV-hIE1 mutant, Tang 
and Maul previously showed a low level of replication in human fibroblasts (50). Those authors 
concluded that HCMV IE1 can help MCMV to cross the species barrier. The reason for this minor 
discrepancy between the two studies is unclear, and further investigation is needed to consolidate 
these findings. However, we believe that it is fair to draw the conclusion that PML disruption has little 
(or no) effect on MCMV replication in human cells, unless the virus carries additional mutations 
facilitating its replication in these cells. Mutations in M112/M113 were sufficient to afford MCMV 
replication in human RPE-1 cells. However, the M112mut virus clearly did not replicate and spread as 
rapidly as MCMV/h (Fig. 5A). Hence, additional mutations in MCMV/h must contribute to its 
remarkably efficient replication. Many of the mutations listed in Table 1 are in largely uncharacterized 
ORFs or noncoding regions of the MCMV genome. Therefore, it is difficult to predict which of them 
contributes to the phenotype. The identification and characterization of additional contributing 
mutations should provide new insights into the functions of as-yet-uncharacterized genes or regulatory 
regions and into the mechanisms of the species specificity of cytomegaloviruses in general. Once we 
have a better understanding of how MCMV can overcome the obstacles to its replication in human 
cells, we might be able to construct HCMV mutants that can replicate in murine cells or even in the 
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Tables and Figures 
 
 
Figure 1. Replication of MCMV/h in human and murine cells. (A to F) Human RPE-1 cells, HFFs, 
MRC-5 cells, and HUVECs were infected at an MOI of 0.2 or 5 TCID50/cell with MCMV/h, MCMV-
bclXL, or the parental wt virus. HCMV strains AD169 and TB40/E are shown for comparison. (G) 
Murine 10.1 fibroblasts were infected with the same viruses described above (A) at an MOI of 0.1 
TCID50/cell. Virus replication was determined by titration. DL, detection limit. (H) Virion DNA was 
extracted from MCMV/h and the parental wt MCMV, digested with restriction enzymes, and separated 
by gel electrophoresis. MCMV and HCMV (strain AD169) BAC DNAs are shown for comparison. 
Differences in the restriction fragment patterns of BAC and virion DNAs are expected, as virion DNA is 
linear and BAC DNA is circular, and BAC DNA contains the BAC replicon in addition to the viral 
genome. The terminal fragments of the virion DNA and the corresponding joined fragment of the BAC 










Figure 2. MCMV/h induces less cell death than the parental wt MCMV. (A) RPE-1 cells were infected 
at an MOI of 5 TCID50/cell. Fluorescent images were taken 24 and 48 hpi. Infected cells show green 
fluorescence, as both viruses express GFP. (B) RPE-1 cells were infected as described above, and 
nuclear DNA fragmentation as a sign of apoptosis was determined at 48 hpi by using a TUNEL assay. 
Fragmented DNA is indicated by red fluorescence. Nuclei were stained with DAPI. (C and D) Human 
RPE-1 cells (C) and murine 10.1 fibroblasts (D) were infected at an MOI of 5 TCID50/cell with MCMV/h, 
the parental wt virus, or MCMV-bclXL. Cell viability was measured by using an MTS assay and is 
shown relative to the viability at 0 hpi. The differences in viability between the wt and MCMV/h at 48 

















Figure 3. Viral gene expression and DNA replication. (A) Human RPE-1 and murine 10.1 cells were 
infected with wt MCMV or MCMV/h. The levels of expression of the viral IE1, E1, M44, and gB proteins 
were determined by Western blotting. (B and C) Viral DNA replication was determined by slot blot 
hybridization (B) or by real-time PCR (C). Viral genome amplification is shown relative to the value 




































Figure 4. Construction of mutant MCMV genomes. (A) Structure of the M112/M113-coding region 
according to data described previously by Ciocco-Schmitt et al. (16). Mutations detected in MCMV/h 
are indicated by arrows, and the predicted changes in the amino acid sequence are shown below. (B) 
An MCMV M112/M113 deletion mutant was constructed by the insertion of a zeocin resistance gene 
(zeo) replacing the M112/M113-coding region. The wt or mutant M112/M113 sequence was then 
reinserted by using a kan gene flanked by FRT sites as a selectable marker. The kan gene was 
subsequently removed by Flp recombination. NheI restriction sites are indicated with N, and the 
expected NheI fragment sizes are shown. (C) wt and mutant BACs were digested with NheI and 



















Figure 5. Viral replication and cell death induction in RPE-1 cells. (A) RPE-1 cells were infected at an 
MOI of 0.2 TCID50/cell with wt and mutant MCMVs as indicated. Virus replication was determined by 
titration. DL, detection limit. (B) RPE-1 cells were infected at an MOI of 5 TCID50/cell. Cell viability was 
measured by using an MTS assay and is shown relative to the viability at 0 hpi. The differences in 
viability between the wt and M112mut at 48 and 72 hpi were significant (P 0.01 by a Student’s t test), 































Figure 6. M112/M113 protein expression and formation of replication compartments. (A) Cells were 
infected with wt and mutant MCMVs. The levels of expression of the IE1, IE3, E1, M44, and gB 
proteins were determined by Western blotting. The 36-, 38-, and 87-kDa E1 proteins were detected on 
the same blot, but a longer exposure is shown for the large 87-kDa isoform, as its level of expression 
is much lower than the levels of expression of the 36- and 38-kDa isoforms. Viral DNA (vDNA) levels 
were determined by Southern blotting. (B and C) Viral replication compartments were stained at 24 hpi 
with antibodies against IE3, M44, and E1. (D) The relative abundances of the two different forms of 
replication compartments at 24 hpi were determined by evaluating more than 150 nuclei per sample in 
four independent experiments. The differences between wt and mutant MCMVs (MCMV/h and 













Figure 7. ND10 disruption by MCMV in human cells. (A) RPE-1 cells were infected with wt MCMV, 
MCMV/h, or HCMV strain AD169. Infected cell nuclei were stained at 24 hpi with antibodies against 
the viral E1 (for MCMV) or IE1 (for HCMV) protein. ND10 was stained with a PML-specific antibody. 
(B) The relative abundance of punctate versus dispersed ND10 was determined by evaluating more 
than 150 nuclei per sample in three independent experiments. Differences between wt and mutant 
MCMVs were significant (P 0.01 by a Student’s t test). (C) RPE-1 cells were transfected with plasmids 
encoding enhanced GFP (EGFP), HCMV or MCMV IE1, and wt or mutant M112/M113 (E1) proteins. 
Transfected cells were stained with antibodies specific for the transiently expressed proteins, and 
ND10 was stained with an anti-PML antibody. (D) RPE-1 cells were transduced with retroviral vectors 
expressing PML- or Daxx-specific shRNAs, a control shRNA, or an empty vector as described 
previously (52). Successful gene knockdown was verified by Western blotting. An unspecific 
background band recognized by the anti-PML antibody is marked with an asterisk. (E) The shRNA-
expressing cells were infected at an MOI of 0.2 TCID50/cell, and the replication kinetics of wt MCMV 










Table 1. Sequence alterations detected in MCMV/h compared to the published sequence of the 





a See reference 27. 
b See reference 1. 
c See reference 9. 
d See references 12 and 17. 
e See references 15 and 54. 
f Reported under GenBank accession number NC_004065 (42). 
  
